Applicability of Video Games and Vibrational Therapy in Reducing Pain Secondary to Breast Cancer
NCT ID: NCT01893944
Last Updated: 2014-02-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2013-01-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Virtual Reality on Pain and Anxiety During Chemotherapy Session in Breast Cancer Patients
NCT07292727
Exercises Using Virtual Reality on Cancer Patients
NCT06058936
e-Nature VR: Evaluation of the Impact of Virtual Reality During Breast Biopsy
NCT03877094
The Use of Virtual Reality During Breast Ultrasound-Guided Biopsy Procedures
NCT05042999
Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy
NCT05440760
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
FACTORIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Virtual Reality
\- Participate in this group 20 women to be treated by means of games Xbox 360 ®, attributed to this, custom applications using virtual and augmented reality to be developed.
virtual reality
customized applications using virtual and augmented reality to be developed.
Vibration therapy
\- participate in this group 20 women who will undergo 15 minutes of continuous vibration by vibration of the upper mantle, with a frequency of 40 Hz, 3 function and intensity tolerable, keeping the limb supported and raised to 120 °.
virtual reality
customized applications using virtual and augmented reality to be developed.
control group
\- participate in this group 20 women who are treated with conventional cinesioterapia through muscle stretching exercises, dissociation girdle, active and active-assisted exercises for groups flexors, extensors, abductors and adductors of the upper limbs, which will be three series 10 repetitions for each exercise.
virtual reality
customized applications using virtual and augmented reality to be developed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
virtual reality
customized applications using virtual and augmented reality to be developed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Submit medical referral;
* Which are not performing radiotherapy or chemotherapy;
* Age 40-70 years;
* Reporting pain, intermittent, prolonged duration and intensity that limits the ADL;
* Lymphedema in the ipsilateral upper limb surgery;
* To agree and sign the Statement of Consent
Exclusion Criteria
* Be a carrier of other types of cancer;
* Have undergone other types of surgery removal of breast cancer; - be doing chemotherapy or radiotherapy;
* Do not complain of pain symptoms and lymphedema;
* Presenting severe joint lock.
40 Years
70 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade do Vale do Paraíba
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lersm, Ip&D
São José dos Campos, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07694812.7.0000.5501
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.